Introduction
With the increasing interest in individualized medicine there is a greater need for robust statistical methods for prediction of optimal treatment based on the patient's characteristics.
When evaluating two treatments, one treatment may not be uniformly superior to the other treatment for all patients. A patient characteristic may interact with one of the treatments and change the effect of the treatment on the response. Clinical trials are also collecting more information on the patient. This additional information on the patients combined with the state-of-the-art in model selection allows researchers to build better optimal treatment algorithms.
In this chapter we introduce a methodology for predicting optimal treatment. The methodology is demonstrated first on a simulation and then on a phase III clinical trial in neuro-oncology.
Predicting Optimal Treatment Based on Baseline Factors
Start with a randomized controlled trial where patients are assigned to one of two treatment arms, A ∈ {0, 1}, with Pr(A = 1) = Π A . The main outcome for the trial is defined at a given time point t as Y = I(T > t) where T is the survival time. For example, the main outcome may be the six-month progression-free rate and T is the progression time.
Also collected at the beginning of the trial is a set of baseline covariates W . The baseline covariates may be any combination of continuous and categorical variables. The baseline covariates can be split into prognostic and predictive factors. Prognostic factors are patient characteristics which are associated with the outcome independent of the treatment given, while predictive factors are patient characteristics which interact with the treatment in their association with the outcome. To determine the optimal treatment, a model for how the predictive factors and treatment are related to the outcome needs to be estimated. The observed data is O i = (W i , A i , Y i = I(T i > t)) ∼ P for i = 1, . . . , n. For now assume Y is observed for all patients in the trial but this assumption is relaxed in the next section.
The optimal treatment given a set of baseline variables is found using the W -specific variable importance parameter: The subscript W is assumed on π Y and left off for clarity of the notation. Adding the treatment variable A into the conditioning statement we define
and {Y |A = 0, W } ∼ Bernoulli(π −1 ). Again the subscript W is dropped for clarity but assumed throughout the paper. The parameter of interest can be expressed as Ψ(W ) = π +1 − π −1 . For a given value of W , Ψ(W ) will fall into one of three intervals with each interval leading to a different treatment decision. The three intervals for Ψ(W ) are:
1. Ψ(W ) > 0 : indicating a beneficial effect of the intervention A = 1.
2. Ψ(W ) = 0 : indicating no effect of the intervention A.
3. Ψ(W ) < 0 : indicating a harmful effect of the intervention A = 1.
Knowledge of Ψ(W ) directly relates to knowledge of the optimal treatment.
As noted in [1] , the parameter of interest can be expressed as:
When Π A = 0.5, the conditional expectation in equation (19.2) can be modeled with the
) and since A and Y are binary variables:
The observed values of Z follow a multinomial distribution. The parameter Ψ(W ) will be high dimensional in most settings and the components of Ψ(W ) are effect modifications between W and the treatment A on the response Y . The parameter can be estimated with a model Ψ(W ) = m(W |β). The functional form of m(W |β) can be specified a priori, but since the components of the model represent effect modifications, knowledge of a reasonable model may not be available and we recommend a flexible approach called the super learner (described in the next section) for estimating Ψ(W ). In many cases a simple linear model may work well for m(W |β), but as the true functional form of Ψ(W ) becomes more complex, the super learner gives the researcher flexibility in modeling the optimal treatment function.
With the squared error loss function for a specific model m(W |β), the parameter estimates are:
The treatment decision for a new individual with covariates W = w is to treat with A = 1 if m(w|β n ) > 0, otherwise treat with A = 0.
A normal super learner model for m(W |β) would allow for a flexible relationship between W and Z but these models do not respect the fact that Ψ(W ) is bounded between −1 and +1. 
When we restrict the data to the cases with Z = 0 (i.e. Y = 1) the outcome becomes a binary variable and binary regression methods can be implemented. For example, the logistic regression model:
The treatment decision is based on m (W i |β n ) > 0 where β n is the maximum likelihood estimate for the logistic regression model. With the binary regression setting, we are now incorporating the distribution information in creating the prediction model, but losing information by working on a subset of the data. These trade-offs depend on the probability π Y and we will evaluate both methods on the trial example below. In the next section we propose a data-adaptive method for estimating Ψ(W ).
Super Learner
Many methods exist for prediction, but for any given data set it is not known which method will give the best prediction. A good prediction algorithm should be flexible to the true data generating distribution. One such algorithm is the super learner [2] . The super learner is applied to predict the optimal treatment based on the observed data. The 
Extensions for Censored Data
In a prospective trial the data may be subject to right censoring. In both methods above, right censoring leads to the outcome Z being missing. The data structure is extended to include an indicator for observing the outcome. Let C be the censoring time (for individuals with an observed outcome we set C = ∞). Define ∆ = I(C > t). ∆ = 1 when the outcome is observed and ∆ = 0 when the outcome is missing. The observed data is the set
For the first method, we propose using the doubly robust censoring unbiased transformation [3] . The doubly robust censoring unbiased transformation generates a new variable Z * which is a function of the observed data but has the additional property:
The transformation allows estimation of the parameter Ψ(W ) by applying the super learner on the uncensored observations with the transformed variable Z * as the outcome. The doubly robust censoring unbiased transformation is: For the second method which relies on modeling E(Z|Z = 0, W ), the main feature was the ability to use the knowledge of the distributions to develop a better model. To retain the binary outcome, the doubly robust censoring unbiased transformation will not work. An alternative method for the right censoring which will retain the binary outcome would be inverse probability of censoring weighting. Inverse probability of censoring weights uses the same π(W ) as above, but does not incorporate the other nuisance parameter Q(W ). When applying the binary super learner for E(Z|Z = 0, W, ∆ = 1) the weights 1/π(W ) will be applied for both the candidate learners and the V-fold cross-validation steps. The super learner will minimize the weighted loss function.
Simulation Example
We first demonstrate the proposed method on a simulation example where the true value of Ψ(W ) is known. The baseline variables were all simulated as normally distributed, W j ∼ N (0, 1), j = 1, . . . , 10. The treatment was randomly assigned with Π A = 0.5. The true model for the outcome was:
Where g −1 (·) is the inverse logit function and W j refers to the j th variable in W . The first method involves the regression of Z on W . We applied the super learner for m(W |β). 10-fold cross validation was used for estimating the candidate learner weights in the super learner. The super learner for the first method included five candidate learners.
The first candidate was ridge regression [4] . Ridge regression used an internal cross validation to select the penalty parameter. Internal cross validation means the candidate learner performed a V-fold cross validation procedure within the folds for the super learner. Structurally, when the candidate learner also performs cross validation within the super learner cross validation we have nested cross validation; therefore, we refer to the candidate learner cross validation as internal cross validation. The second candidate was random forests [5] .
For the random forest candidate learner, 1000 regression trees were grown. The third candidate was least angle regression [6] . An internal 10-fold cross validation procedure was used to determine the optimal ratio of the L1 norm of the coefficient vector compared to the L1 norm of the full least squares coefficient vector. The fourth candidate was adaptive regression splines for a continuous outcome [7] . The final candidate was linear regression. The prediction model from the super learner is: often disappear resulting in a better predictor. The third largest coefficient from the linear regression model is on W 6 which is also a strong effect modifier in the true model. To evaluate how the super learner is performing in comparison to the other candidate learners, each candidate learner was also fit as a separate estimate. We looked at two risk values, first the E(Ψ n (W ) − Z) 2 which was minimized by each algorithm. For the simulation, the riskÊ(Z − Ψ(W )) 2 = 0.540 gives a lower bound for the risk E(Ψ n (W ) − Z) 2 . Since the true Ψ(W ) is known in the simulation, the risk E(Ψ n (W ) − Ψ(W )) 2 was also evaluated. The super learner for the second method included three candidate learners. The first candidate was adaptive regression splines for polychotomous outcomes [8] . The second candidate was the step-wise penalized logistic regression algorithm [9] . The final candidate was main terms logistic regression. The super learner for the second method is:
Where X j n is the predicted value for Z based on the j th candidate learner. j = poly is the polyclass adaptive spline model. j = plr is the penalized logistic regression model. j = glm is the main effects logistic regression model.
Example of Prediction Model on Clinical Trial
A phase III clinical trial was conducted to evaluate a novel treatment for brain metastasis.
The study recruited 554 patients with newly diagnosed brain metastasis and the patients were randomized to receive either standard care (A = 0) or the novel treatment (A = 1). The researchers were interested in determining an optimal treatment to maximize the probability of surviving 6 months from treatment initiation without progression. Of the 554 patients, 246
are censored prior to 6 months. For the 308 patients with an observed 6 month progression time, 130 progressed or died (42.2%). In addition to the treatment and event time data, the researchers collected baseline prognostic and predictive factors on every patient. We apply the super learner to estimate a model for selecting the optimal treatment given a patient's baseline factors. A breakdown of the sample size and treatment allocations available for each method is given in The targeted maximum likelihood variable importance measure as outlined in [11] was then applied using the predictions from the super learner as the initial estimate of E(Z|W ). The targeted effect modification parameter is then: 
Discussion
Two methods were proposed for predicting the optimal treatment based on baseline factors. The first method involves modeling Z on W disregarding the knowledge that E(Z|W )
is bounded between −1 and +1. The second method incorporates the bounds, but does so at a cost in sample size by modeling E(Z|Z = 0, W ). The second method predicts a scaled version of the parameter of interest, and so is still valid for making treatment decisions.
In the simulation and trial example presented here, the loss of sample size in the second In the trial example, the super learner did perform better than the main terms linear regression based on the estimate of the risk E(Ψ n (W ) − Z) 2 . Even though the super learner has shown to have excellent performance across a range of simulations [2, 12] and in various of our data analyses in breast cancer research, there is a risk that the super learner will result in a slight over-fit. In the data analysis we observed that the super learner was ranked third, but competitive with the top two candidate learners, LARS and MARS. We have also
proposed an extension to the super learner outlined here to adaptively select the number of candidates [13] so that the weaker candidates are not selected, which we believe will protect the super learner against possible over-fitting, but this was not implemented in the current data analysis yet.
We observed that the difference in sample size between the two methods may make the second method unusable in this example, but the two methods also differed in the treatment of right censoring. The first method incorporated the doubly robust censoring unbiased transformation while the second method used the inverse probability of censoring weights. If the model for Q(W ) was correctly specified, but the model for the censoring mechanism was not consistently estimating π(W ), the doubly robust estimator would still be unbiased but the inverse probability of censoring weighted method will be biased. Alternatively, if π(W ) was correctly specified, but Q(W ) was inconsistent, then both methods will be unbiased.
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The doubly robust transformation gives the researcher two chances to correctly the nuisance parameters, while the inverse weighting method relies solely on the model for π(W ). When there is uncertainty regarding the model for the censoring mechanism, the doubly robust transformation is preferred.
The methods presented above are not limited to randomized clinical trials. Optimal treatment prediction models could also be estimated from observational or registry data sets. As long as the variables needed to estimate Pr(A = 1|W )) are collected in the study the above methods easily extend to the non-randomized setting. Registry data sets are often larger than randomized trials and therefore have more power to detect the interaction effects necessary for predict optimal treatments.
